Stay updated on CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.

Latest updates to the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page
- Check7 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, signaling a minor maintenance release rather than a substantive update to content or features.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe revision label on the page was updated to v3.5.3, replacing the prior v3.5.2, which reflects a new build of the page.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check57 days agoChange DetectedA new Revision: v3.5.0 label appears, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check72 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3 in the footer. This is a metadata update and does not affect study details or user actions.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page now shows Revision: v3.4.2, and the previous Notice about lapse in government funding and Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.